Comparative Effectiveness Studies

Comparative effectiveness research (CER) is the “real-world” comparison of new therapies with existing standards of care in order to identify the most effective practices for typical patient care settings. CER is being adopted more widely than ever as a model for U.S. healthcare. CER presents opportunities as well as challenges for biopharmaceutical and medical device manufacturers. This web seminar will address the role of CER in the product lifecycle, describe its evolving methodologies and standards, and focus on planning and development of comparative effectiveness studies to demonstrate product value in an increasingly value-driven U.S. healthcare system.

• Discuss the recent evolution of comparative effectiveness research
• Describe the implications of comparative effectiveness research for product development
• Plan and design comparative effectiveness studies

• Product and Marketing Managers
• Clinical Research and Medical Affairs Managers
• Health Outcomes/Health Economics Professionals
• Product Reimbursement Strategists

David Stier, M.D.

Click here for complete trainer biographies 

$695

Includes up to 20 participants at one site. All participants (up to 20) are eligible for “Certificates of Attendance,” and accreditation, provided that accreditation requirements are met. For groups larger than 20 or for additional sites, please call 1-800-856-2556 for pricing.

Barnett International is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education.  Participants will receive 1.5 hours (0.15 CEUs) of continuing education credit for full participation, including the completion of a pre-test, post-test, and program evaluation.  Barnett International will mail ACPE statements within three weeks of program completion.  ACPE#: 0778-0000-12-063-L01-P. Released: 10/12.

Hold this course at your company! For more information, contact Naila Ganatra at (215) 413-2471.